CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF MEDICAL OFFICER sold 8,216 shares at an average $10.02 ($82,342)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 26,631 shares at an average $10.02 ($266,953)
- 4 Option exercise Director acquired 1,210 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 19,289 shares at an average $8.49 ($163,673)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 7,217 shares at an average $8.49 ($61,238)
- 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 4,211 shares at an average $8.49 ($35,731)
- 4 Option exercise GENERAL COUNSEL & CORP SEC acquired 13,475 shares (option exercise)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 23,100 shares (option exercise)
- 4 Option exercise CEO acquired 61,750 shares (option exercise)
- 4 Option exercise CEO acquired 35,000 shares (option exercise)
Page 5 of 16 · 305 filings